A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Status: Completed
Location: See all (39) locations...
Study Type: Observational
SUMMARY
This is a 5-year, longitudinal, observational study of patients with PBC designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult patients (age 18 or older) being treated or managed for PBC
Locations
United States
Arkansas
University of Arkansas
Little Rock
Arizona
Institute for Liver Health
Chandler
Banner University Medical Center
Phoenix
Mayo Clinic
Phoenix
California
Stanford University Medical Center
Palo Alto
California Liver Research Institute
Pasadena
University of California Davis
Sacramento
Colorado
University of Colorado- Anschutz Medical Campus
Aurora
Connecticut
Yale Internal Medicine, Digestive Diseases
New Haven
Florida
Gastro Florida
Clearwater
University of Florida Hepatology Research
Gainesville
SCFLD/University of Miami
Miami
Georgia
Piedmont Atlanta Hospital
Atlanta
Iowa
University of Iowa
Iowa City
Illinois
Illinois Gastroenterology Group
Arlington Heights
Rush University Medical Center
Chicago
University of Chicago
Chicago
Maryland
Mercy Medical Center, GI Research
Baltimore
Michigan
University of Michigan
Ann Arbor
Missouri
Saint Louis University
Saint Louis
Mississippi
Southern Therapy and Advanced Research LLC (STAR)
Jackson
North Carolina
University of North Carolina at Chapel Hill
Chapel Hill
Center for Liver Disease and Transplant at CMC
Charlotte
Duke University Medical Center
Durham
Nebraska
University of Nebraska
Omaha
New York
Sandra Atlas Bass Center for Liver Diseases
Manhasset
Columbia University Medical Center
New York
NYU Langone Health
New York
Weill Cornell Medical College
New York
Ohio
Ohio State University Medical Center
Columbus
Pennsylvania
University of Pennsylvania
Philadelphia
Texas
UT Southwestern Medical Center
Dallas
Baylor,Scott and White All Saints
Fort Worth
Liver Associates of Texas, P.A.
Houston
Pinnacle Clinical Research
Live Oak
Virginia
Bon Secours Liver Institute of Virginia
Richmond
Virginia Commonwealth University (VCU)
Richmond
Washington
University of Washington
Seattle
Wisconsin
University of Wisconsin
Madison
Time Frame
Start Date: 2016-10
Completion Date: 2025-01-23
Participants
Target number of participants: 1500
Authors
Cynthia Levy, Charles Landis, Sujit Janardhan, Michael Weiss, Ester Little, Michael Lucey, Richard Manch, Carmen Stanca, Elizabeth Verna, Lisa Forman, Fedja Rochling, Victor Ankoma-Sey, Aparna Goel, Marlyn Mayo, Raymond Rubin, Gautham Reddy, Anna Lok, David Bernstein, Brian Borg, Lindsay King, David Goldberg, Mitchell Shiffman, Bruce Bacon, Jama Darling, Jonathan Dranoff, Randhir Jesudoss, Paul Thuluvath, Christopher Bowlus
Related Therapeutic Areas
Sponsors
Leads: Target PharmaSolutions, Inc.